Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies

por Kerepesi, Csaba, Bakacs, Tibor, Moss, Ralph W., Slavin, Shimon, Anderson, Colin C.
Publicado 2020